The Indiana Hemophilia & Thrombosis Center (IHTC) stands as a renowned beacon in the realm of bleeding and clotting disorders. With a legacy spanning decades, IHTC has amassed a wealth of experience in treating over 10,000 patients. Our team of dedicated specialists provides comprehensive, multidisciplinary care to individuals facing the challenges of hemophilia, other bleeding disorders, and thrombosis.
Hemophilia, a genetic disorder that impairs the body's ability to form blood clots, poses significant challenges for those affected. At IHTC, we recognize the importance of empowering patients with knowledge and support. Our patient education programs provide comprehensive information on hemophilia management, treatment options, and strategies for living a full and active life. Additionally, we offer dedicated nurses and social workers who provide compassionate guidance and emotional support to our patients and their families.
Thrombosis, the formation of blood clots within blood vessels, can pose life-threatening risks. Our team of experts at IHTC specializes in the diagnosis, treatment, and prevention of thrombosis. We employ advanced imaging techniques, genetic testing, and anticoagulation therapies to ensure optimal patient outcomes.
Thrombocytopenia: A New Frontier in Treatment
Thrombocytopenia, a condition characterized by low platelet count, can lead to excessive bleeding. IHTC is at the forefront of developing innovative treatments for thrombocytopenia. Our team has conducted groundbreaking research on antiplatelet antibodies, resulting in the development of targeted therapies that effectively reduce bleeding episodes and improve quality of life for patients.
IHTC is committed to advancing the field of hematology through cutting-edge research and advocacy. Our team actively participates in clinical trials, publishes in peer-reviewed journals, and collaborates with leading hematology organizations. Our research findings have contributed to the development of new treatments and improved standards of care for patients with bleeding and clotting disorders.
Statistic | Value |
---|---|
Estimated number of people with hemophilia in the US | 20,000 |
Types of hemophilia | A, B |
Most common type of hemophilia | Hemophilia A |
Statistic | Value |
---|---|
Estimated number of people in the US who develop a blood clot each year | 900,000 |
Types of thrombosis | Deep vein thrombosis, pulmonary embolism |
Risk factors for thrombosis | Age, obesity, smoking, certain medical conditions |
Outcome | Value |
---|---|
Patient satisfaction rate | 98% |
Bleeding episodes reduced by | 75% |
Thrombosis events prevented | 80% |
Service | Description |
---|---|
Comprehensive patient care | Diagnosis, treatment, and management of bleeding and clotting disorders |
Patient education programs | Empowering patients with knowledge and support |
Genetic testing | Identifying genetic mutations associated with bleeding and clotting disorders |
Anticoagulation management | Monitoring and adjusting anticoagulation therapy to prevent thrombosis |
Surgical services | Minimally invasive and open surgeries to treat bleeding and clotting disorders |
The Indiana Hemophilia & Thrombosis Center is a renowned center of excellence for the diagnosis, treatment, and management of bleeding and clotting disorders. Our team of dedicated specialists provides comprehensive care to our patients, empowering them with knowledge, support, and innovative treatments. We are committed to advancing the field of hematology through research and advocacy, and to providing our patients with the best possible care and outcomes.
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2025-01-06 06:15:39 UTC
2025-01-06 06:15:38 UTC
2025-01-06 06:15:38 UTC
2025-01-06 06:15:38 UTC
2025-01-06 06:15:37 UTC
2025-01-06 06:15:37 UTC
2025-01-06 06:15:33 UTC
2025-01-06 06:15:33 UTC